Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
To bill or not to bill - a cross-sectional study comparing funded and unfunded advance care planning services in German nursing homes. [PDF]
Schleef T +8 more
europepmc +1 more source
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Status of financial toxicity and its influence on quality of life in patients with gynecological malignancies in China. [PDF]
Zhang L +10 more
europepmc +1 more source
The current state of oncological emergency services in Kenya: challenges and opportunities. [PDF]
Abdihamid O +3 more
europepmc +1 more source
Evaluate operational performance and scale efficiency in non- life insurance companies in Egypt
دينا نيل
openalex +1 more source
Physical Therapy Is an Underutilized Health Resource for Children with Cancer: A Retrospective Study Identifies Facilitators for Improvement. [PDF]
Marchese V +5 more
europepmc +1 more source
Machine learning-based prediction of dissatisfaction after occupational injury: a retrospective cohort study using the nationwide Korean workers' compensation insurance database. [PDF]
Lee Y, Kim T, Koo D, Park D.
europepmc +1 more source
The non-life insurance market in Ireland : prospects for empirical analysis
Vincent Hogan, Colm Harmon
openalex +1 more source

